뇌 영상 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Brain Imaging Devices Market Size, Share & Trends Analysis Report By Product (Devices, Accessories), By Application (Stroke, Brain Tumor), By Modality (Fixed, Portable), By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,641,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,094,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,998,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

뇌 영상 기기 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 뇌 영상 기기 시장 규모는 2030년까지 90억 3,000만 달러에 달할 것으로 예상되며, 2025년부터 2030년까지 연평균 8.2%의 성장률을 보일 것으로 예상됩니다.

시장 성장을 촉진하는 주요 요인으로는 기술 발전, 연구개발 활동 증가, 뇌 및 신경 질환의 유병률 증가 등이 있습니다. 예를 들어, 국제암연구소는 2022년 전 세계적으로 약 32만 1,731건의 뇌 및 중추신경계 암이 발생할 것으로 예상했습니다. 이 유형의 암은 다른 모든 유형의 암 중에서 19위를 차지할 것으로 지적되고 있습니다.

기술 발전은 시장 성장에 기여하는 주요 요인 중 하나가 될 것으로 예상됩니다. 이러한 발전에는 영상 해상도 향상, 데이터 처리 능력 향상, 새로운 영상 양식 개발 등 다양한 혁신이 포함됩니다. 이러한 발전은 뇌 영상의 정확성과 효율성을 향상시킬 뿐만 아니라 신경과학, 신경학, 정신의학, 신경외과 등 다양한 분야로의 적용을 확대할 수 있습니다. 예를 들어, 필립스는 2024년 2월 자기공명영상법(MRI) 소프트웨어 솔루션 전문 기업인 Synthetic MR과 제휴하여 다발성 경화증(MS), 외상성 뇌손상(TBI), 치매 등 뇌질환의 진단 및 치료 효과 평가에 객관적인 의사결정 지원을 제공하는 주목할 만한 Smart Quant Neuro 3D 기술은 다양한 뇌 조직의 자동 측정을 제공하고, 뇌 질환에 대한 의사결정을 지원하고, 질병의 진행을 모니터링하고, 치료 결과를 평가합니다.

또한, 신경 질환의 유병률 증가와 인구 고령화는 첨단 뇌 영상 기술에 대한 수요 증가에 기여하고 있습니다. 지속적인 연구개발이 기술 혁신과 시장 확대의 원동력이 되고 있습니다. 또한, 시장 진입 기업들의 다양한 노력이 시장 성장에 더욱 기여할 것으로 예상됩니다. 예를 들어, 2022년 11월 Neurosteer는 단일 채널 뇌파(EEG) 뇌 모니터링 플랫폼에 대한 FDA 승인을 획득했습니다. 이 회사는 접착제가 내장된 전극 스트립을 통합하여 기존 EEG 시스템을 혁신적으로 개선하고, 소형 센서에 원활하게 연결하여 보다 단순하고 사용자 친화적인 솔루션을 제공합니다.

뇌 영상 기기 보고서 하이라이트

• 2024년 매출 비중은 디바이스 부문이 81.5%로 가장 큽니다.
• 뇌종양 부문은 2024년 가장 큰 매출 점유율을 차지했습니다.
• 2024년 가장 큰 매출 점유율을 차지한 것은 고정 부문이었습니다.
• 병원 부문은 2024년 가장 큰 매출 점유율을 차지했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 뇌 영상 기기 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상부 시장 전망
  • 관련/보조 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 뇌 영상 기기 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 뇌 영상 기기 시장 : 제품별 추정·동향 분석

• 부문 대시보드
• 뇌 영상 기기 시장 : 변동 분석
• 세계의 뇌 영상 기기 시장 규모와 동향 분석(2018-2030년)
• 디바이스
  • EEG
  • MEG
  • MRI
  • CT
  • PET
  • 기타 디바이스
• 액세서리
  • 전극
  • 센서
  • 기타 액세서리

제5장 뇌 영상 기기 시장 : 용도별 추정·동향 분석

• 부문 대시보드
• 뇌 영상 기기 시장 : 변동 분석
• 세계의 뇌 영상 기기 시장 규모와 동향 분석(2018-2030년)
• 뇌졸중
• 뇌종양
• 외상성 뇌손상(TBI)
• 간질
• 수면무호흡증
• 두통
• 구조 이상
• 기타 용도

제6장 뇌 영상 기기 시장 : 모달리티별 추정·동향 분석

• 부문 대시보드
• 뇌 영상 기기 시장 : 변동 분석
• 세계의 뇌 영상 기기 시장 규모와 동향 분석(2018-2030년)
• 고정
• 휴대용
• 웨어러블

제7장 뇌 영상 기기 시장 : 최종 용도별 추정·동향 분석

• 부문 대시보드
• 뇌 영상 기기 시장 : 변동 분석
• 세계의 뇌 영상 기기 시장 규모와 동향 분석(2018-2030년)
• 병원
• 진단 영상 센터
• 외래 수술 센터
• 기타 최종사용자

제8장 뇌 영상 기기 시장 : 지역별 추정·동향 분석

• 지역 시장 대시보드
• 지역별 시장 점유율 분석, 2024년 및 2030년
• 지역별 뇌 영상 기기 시장 : 주요 포인트
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제9장 경쟁 구도

• 주요 시장 진입 기업의 최근 동향과 영향 분석
• 기업/경쟁 분류
• 벤더 상황
• 기업 개요
  • GE HealthCare
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Medtronic
  • Compumedics Limited
  • MEGIN
  • CTF MEG NEURO INNOVATIONS, INC.
  • FieldLine Inc.
  • Cerca Magnetics Limited
  • Advanced Brain Monitoring, Inc.
  • Canon Medical Systems Corporation
  • Natus
  • Magstim EGI
  • Cadwell Industries Inc.
  • Nihon Kohden Corporation
  • NeuroLogica Corp.

ksm

영문 목차

영문목차

Brain Imaging Devices Market Growth & Trends:

The global brain imaging devices market size is estimated to reach USD 9.03 billion by 2030, registering to grow at a CAGR of 8.2% from 2025 to 2030 according to a new report by Grand View Research, Inc. Key drivers propelling market growth include technological advancements, increasing R&D activities, and the growing prevalence of brain or neurological disorders. For instance, the International Agency for Research on Cancer reported approximately 321,731 cases of brain and central nervous system cancer worldwide in 2022. This type of cancer was noted to rank 19th among all other types of cancer.

Technological advancements are expected to be one of the primary factors contributing to market growth. These advancements encompass a spectrum of innovations, including enhanced imaging resolution, improved data processing capabilities, and the development of novel imaging modalities. Such progress not only enhances the accuracy and efficiency of brain imaging but also expands its applications across various fields such as neuroscience, neurology, psychiatry, and neurosurgery. For instance, in February 2024, Philips partnered with Synthetic MR, a company specializing in magnetic resonance imaging (MRI) software solutions, to introduce Smart Quant Neuro 3D, marking a notable advancement in providing objective decision support for the diagnosis and assessment of therapy effectiveness in brain disorders like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. The Smart Quant Neuro 3D technology provides automated measurements of various brain tissues, aids in decision-making for brain diseases, monitors disease progression, and assesses therapy results.

Additionally, the rising prevalence of neurological disorders and an aging population contribute to the increasing demand for advanced brain imaging technologies. With continuous research and development efforts driving innovation and the expansion of the market. Furthermore, various initiatives undertaken by market players are further expected to contribute to market growth. For instance, in November 2022, Neurosteer secured FDA approval for its single-channel electroencephalogram (EEG) brain monitoring platform. The company innovatively improved the conventional EEG system by incorporating an adhesive-backed electrode strip, seamlessly linking to a compact sensor, thus offering a more simplified and user-friendly solution.

Brain Imaging Devices Report Highlights:

• The devices segment dominated the market with the largest revenue share of 81.5% in 2024.
• The brain tumor segment held the largest revenue share in 2024, attributed to the increasing prevalence of the condition.
• The fixed segment dominated the brain imaging devices industry with the largest revenue share in 2024.
• The hospital segment held the largest revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Modality
  • 1.2.4. End Use
  • 1.2.5. Regional Scope
  • 1.2.6. Estimates and Forecasts Timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
  • 1.4.5. Details of Primary Research
• 1.5. Information or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Application Outlook
  • 2.2.3. Modality Outlook
  • 2.2.4. End Use Outlook
  • 2.2.5. Regional Outlook
• 2.3. Competitive Scenario

Chapter 3. Brain Imaging Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Brain Imaging Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political Landscape
    • 3.3.2.2. Technological Landscape
    • 3.3.2.3. Economic Landscape

Chapter 4. Brain Imaging Devices Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Brain Imaging Devices Market: Product Movement Analysis
• 4.3. Global Brain Imaging Devices Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
• 4.4. Devices
  • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.2. EEG
    • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.3. MEG
    • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.4. MRI
    • 4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.5. CT
    • 4.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.6. PET
    • 4.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.4.7. Other Devices
    • 4.4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 4.5. Accessories
  • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.2. Electrodes
    • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.3. Sensors
    • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5.4. Other Accessories
    • 4.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Brain Imaging Devices Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Brain Imaging Devices Market: Application Movement Analysis
• 5.3. Global Brain Imaging Devices Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
• 5.4. Stroke
  • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.5. Brain Tumor
  • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.6. Traumatic Brain Injury (TBI)
  • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.7. Epilepsy
  • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.8. Sleep Apnea
  • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.9. Headache
  • 5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.10. Structural Anomalies
  • 5.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 5.11. Other Applications
  • 5.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Brain Imaging Devices Market: Modality Estimates & Trend Analysis

• 6.1. Modality Segment Dashboard
• 6.2. Brain Imaging Devices Market: Modality Movement Analysis
• 6.3. Global Brain Imaging Devices Market Size & Trend Analysis, By Modality, 2018 to 2030 (USD Million)
• 6.4. Fixed
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.5. Portable
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 6.6. Wearable
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Brain Imaging Devices Market: End Use Estimates & Trend Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Brain Imaging Devices Market: End Use Movement Analysis
• 7.3. Global Brain Imaging Devices Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
• 7.4. Hospital
  • 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.5. Diagnostic Imaging Centers
  • 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.6. Ambulatory Surgery Centers
  • 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 7.7. Other End Users
  • 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Brain Imaging Devices Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Regional Market Share Analysis, 2024 & 2030
• 8.3. Brain Imaging Devices Market by Region: Key Takeaways
• 8.4. North America
  • 8.4.1. U.S.
    • 8.4.1.1. Key Country Dynamics
    • 8.4.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.4.1.3. Competitive Scenario
    • 8.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Canada
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.4.2.3. Competitive Scenario
    • 8.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.4.3. Mexico
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.4.3.3. Competitive Scenario
    • 8.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. U.K.
    • 8.5.1.1. Key Country Dynamics
    • 8.5.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.1.3. Competitive Scenario
    • 8.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.2. Germany
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.3. France
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Italy
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.4.3. Competitive Scenario
    • 8.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.5. Spain
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.5.3. Competitive Scenario
    • 8.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Denmark
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.6.3. Competitive Scenario
    • 8.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.7.3. Competitive Scenario
    • 8.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.5.8. Norway
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Regulatory Framework/ Reimbursement Structure
    • 8.5.8.3. Competitive Scenario
    • 8.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Japan
    • 8.6.1.1. Key Country Dynamics
    • 8.6.1.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.1.3. Competitive Scenario
    • 8.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.2. China
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.3. India
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.4. Australia
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.6.6. Thailand
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Regulatory Framework/ Reimbursement Structure
    • 8.6.6.3. Competitive Scenario
    • 8.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.7.2.3. Competitive Scenario
    • 8.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.7.3.3. Competitive Scenario
    • 8.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
• 8.8. Middle East and Africa
  • 8.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.2.3. Competitive Scenario
    • 8.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.3.3. Competitive Scenario
    • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.4.3. Competitive Scenario
    • 8.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Regulatory Framework/ Reimbursement Structure
    • 8.8.5.3. Competitive Scenario
    • 8.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company/ Competition Categorization
• 9.3. Vendor Landscape
  • 9.3.1. Key Company Heat Map Analysis, 2024
• 9.4. Company Profiles
  • 9.4.1. GE HealthCare
    • 9.4.1.1. Company Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Koninklijke Philips N.V.
    • 9.4.2.1. Company Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Siemens Healthineers AG
    • 9.4.3.1. Company Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Medtronic
    • 9.4.4.1. Company Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Compumedics Limited
    • 9.4.5.1. Company Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. MEGIN
    • 9.4.6.1. Company Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. CTF MEG NEURO INNOVATIONS, INC.
    • 9.4.7.1. Company Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. FieldLine Inc.
    • 9.4.8.1. Company Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Cerca Magnetics Limited
    • 9.4.9.1. Company Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Advanced Brain Monitoring, Inc.
    • 9.4.10.1. Company Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives
  • 9.4.11. Canon Medical Systems Corporation
    • 9.4.11.1. Company Overview
    • 9.4.11.2. Financial Performance
    • 9.4.11.3. Product Benchmarking
    • 9.4.11.4. Strategic Initiatives
  • 9.4.12. Natus
    • 9.4.12.1. Company Overview
    • 9.4.12.2. Financial Performance
    • 9.4.12.3. Product Benchmarking
    • 9.4.12.4. Strategic Initiatives
  • 9.4.13. Magstim EGI
    • 9.4.13.1. Company Overview
    • 9.4.13.2. Financial Performance
    • 9.4.13.3. Product Benchmarking
    • 9.4.13.4. Strategic Initiatives
  • 9.4.14. Cadwell Industries Inc.
    • 9.4.14.1. Company Overview
    • 9.4.14.2. Financial Performance
    • 9.4.14.3. Product Benchmarking
    • 9.4.14.4. Strategic Initiatives
  • 9.4.15. Nihon Kohden Corporation
    • 9.4.15.1. Company Overview
    • 9.4.15.2. Financial Performance
    • 9.4.15.3. Product Benchmarking
    • 9.4.15.4. Strategic Initiatives
  • 9.4.16. NeuroLogica Corp.
    • 9.4.16.1. Company Overview
    • 9.4.16.2. Financial Performance
    • 9.4.16.3. Product Benchmarking
    • 9.4.16.4. Strategic Initiatives

관련자료